Hjem › Merkelcellecarcinom
Merkelcellecarcinom kliniske forsøg rekrutterer i USA
24 studier for Merkelcellecarcinom rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Houston, TX6 studier
- Boston, MA5 studier
- Tampa, FL4 studier
- New York City, NY4 studier
- San Antonio, TX4 studier
- Seattle, WA3 studier
- Queens, NY3 studier
- Arlington, VA3 studier
- Jacksonville, FL3 studier
- Miami, FL3 studier
- Pittsburgh, PA3 studier
- Los Angeles, CA3 studier
- St. Louis, MO3 studier
- Washington, DC3 studier
- Nashville, TN3 studier
Efter delstat
- Californien5 studier
- Florida11 studier
- Maryland3 studier
- Massachusetts5 studier
- Michigan5 studier
- Missouri3 studier
- New Jersey3 studier
- New York4 studier
- North Carolina3 studier
- Pennsylvania4 studier
- Tennessee3 studier
- Texas8 studier
- Virginia3 studier
- Washington4 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07285044Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT05583708Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06047379Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
RekruttererFase 1
Alder 18 til 100 · Alle køn · Opdateret 22. sep. 2026 · NCT07006727Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
RekruttererFase 1/2
Alder 18 til 99 · Alle køn · Opdateret 22. sep. 2026 · NCT06814496Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
1 Day – 100 Years · Alle køn · Opdateret 22. sep. 2026 · NCT02471352A Study of CRD3874-SI in People With Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT06021626Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT05267626Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
RekruttererFase 2
Alle aldre · Alle køn · Opdateret 4. sep. 2026 · NCT02479698Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 31. aug. 2026 · NCT05896839Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
RekruttererFase 1/2
Alder 16 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT05269381A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT07115043A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 12. aug. 2026 · NCT05859074A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 11. aug. 2026 · NCT05592626A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT07749586Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 16. jul. 2026 · NCT05100095Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 25. jun. 2026 · NCT04975152MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 11. jun. 2026 · NCT05076760Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 17. apr. 2026 · NCT06947928EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers
RekruttererFase 2
Alder 18 til 99 · Alle køn · Opdateret 10. mar. 2026 · NCT06223659Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 18. feb. 2026 · NCT05496036TIL Therapy in cSCC and MCC
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 13. feb. 2026 · NCT07288073IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 15. okt. 2025 · NCT06940440A Beta-only IL-2 ImmunoTherapY Study
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 9. jul. 2025 · NCT05086692Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.